4563.T
Price:
$66
Market Cap:
$22.32B
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of critical limb ischemia, a serious impairment of blood circulation in the leg. The company is also developing NF-kB Decoy Oligonucleotide, a nucleic acid medicine that suppresses inflammation for diseases, including low back pain; drugs for treating atopic dermatitis and disc degeneration; medical devices for the prevention of vascular restenosis; cervical intraepithelial neoplasia therapeutic vaccines for cervical cancer; and DNA vaccines for high blood pressure through collaborative r...[Read more]
Industry
Biotechnology
IPO Date
2002-09-25
Stock Exchange
JPX
Ticker
4563.T
According to AnGes, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.58. This represents a change of -47.63% compared to the average of -1.11 of the last 4 quarters.
The mean historical PE Ratio of AnGes, Inc. over the last ten years is -9.03. The current -0.58 PE Ratio has changed 542.57% with respect to the historical average. Over the past ten years (40 quarters), 4563.T's PE Ratio was at its highest in in the September 2023 quarter at 147.82. The PE Ratio was at its lowest in in the June 2020 quarter at -61.54.
Average
-9.03
Median
-3.73
Minimum
-35.24
Maximum
-0.44
Discovering the peaks and valleys of AnGes, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 277.52%
Maximum Annual PE Ratio = -0.44
Minimum Annual Increase = -88.27%
Minimum Annual PE Ratio = -35.24
Year | PE Ratio | Change |
---|---|---|
2024 | -0.44 | -75.80% |
2023 | -1.83 | 41.62% |
2022 | -1.29 | -68.71% |
2021 | -4.14 | -88.27% |
2020 | -35.24 | 97.51% |
2019 | -17.84 | 69.38% |
2018 | -10.53 | -15.97% |
2017 | -12.54 | 277.52% |
2016 | -3.32 | 7.59% |
2015 | -3.09 | -48.19% |
The current PE Ratio of AnGes, Inc. (4563.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.19
5-year avg
-8.59
10-year avg
-9.03
AnGes, Inc.’s PE Ratio is less than DCM Holdings Co., Ltd. (10.27), less than LINTEC Corporation (10.88), less than TSUKADA GLOBAL HOLDINGS Inc. (5.40), greater than DLE Inc. (-9.27), less than Dowa Holdings Co., Ltd. (9.66),
Company | PE Ratio | Market cap |
---|---|---|
10.27 | $175.92B | |
10.88 | $186.21B | |
5.40 | $27.64B | |
-9.27 | $5.99B | |
9.66 | $266.96B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AnGes, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AnGes, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AnGes, Inc.'s PE Ratio?
How is the PE Ratio calculated for AnGes, Inc. (4563.T)?
What is the highest PE Ratio for AnGes, Inc. (4563.T)?
What is the 3-year average PE Ratio for AnGes, Inc. (4563.T)?
What is the 5-year average PE Ratio for AnGes, Inc. (4563.T)?
How does the current PE Ratio for AnGes, Inc. (4563.T) compare to its historical average?